LSE - Delayed Quote • GBp
ANGLE plc (AGL.L)
As of 10:24 AM GMT+1. Market Open.
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Andrew David William Newland ACA, Meng | Founder, CEO & Executive Director | 264k | -- | 1961 |
| Mr. Ian Francis Griffiths ACA, BA | CFO, Finance Director, Company Secretary & Executive Director | 164k | -- | 1964 |
| Mr. Martin Cooke | Director of Operations & Regulatory Affairs | -- | -- | 1969 |
| Dr. Karen Miller Ph.D. | Chief Scientific Officer | -- | -- | -- |
| Mr. Andrew John Holder | Head of Investor Relations | -- | -- | 1968 |
| Ms. Anne-Sophie Pailhes-Jimenez | Head of R&D and Senior Director | -- | -- | -- |
| Mr. Brett Swansiger | Chief Commercial Officer | -- | -- | -- |
| Mr. Nick Claxton | Senior Vice President of Commercial Operations | -- | -- | -- |
ANGLE plc
Surrey Research Park
10 Nugent Road
Guildford, GU2 7AF
United Kingdom
- Sector:
- Healthcare
- Industry: Diagnostics & Research
- Full Time Employees:
- 173
Description
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Corporate Governance
ANGLE plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Apr 25, 2024 - Apr 26, 2024
ANGLE plc Earnings Call
Related Tickers
GDR.L genedrive plc
5.37
-12.37%
ABDX.L Abingdon Health Plc
10.70
+1.90%
SHC Sotera Health Company
11.27
-0.97%
GENE Genetic Technologies Limited
2.2500
-6.25%
CHEK Check-Cap Ltd.
2.2200
-1.33%
RDNT RadNet, Inc.
48.67
-0.33%
LONN.SW Lonza Group AG
518.00
-0.92%
PRE Prenetics Global Limited
4.7900
+4.81%
MTD Mettler-Toledo International Inc.
1,235.37
-0.48%
VNRX VolitionRx Limited
0.8000
-5.88%